| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.21 | 3e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0005 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |